Short communicationThe effect of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the distribution and excretion of mercuric chloride in rats
References (9)
Arch. Toxicol.
(1976)- et al.
Int. Arch. Gewerbepath. Gewerbehyg.
(1967) Arch. toxicol.
(1978)- et al.
J. Pharm. Pharmacol.
(1975)
Cited by (48)
Effect of DMPS and DMSA on the Placental and Fetal Disposition of Methylmercury
2009, PlacentaCitation Excerpt :The ability of mercuric ions to be extracted from placental and/or fetal tissues has not been examined thoroughly. Although it is well-established that the metal chelators, 2,3-dimercaptopropane-1-sulfonate (DMPS) and 2,3-dimercaptosuccinic acid (DMSA) can reduce the total body burden of CH3Hg+ [17–20], the ability of either chelator to extract mercuric ions from placental or fetal tissues has not been shown. Interestingly, administration of DMPS to pregnant mice exposed orally to CH3Hg+ appeared to protect fetuses from the toxic effects of methylmercury [21].
MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA
2009, Toxicology and Applied PharmacologyMolecular mechanisms triggered by mercury
2008, ToxicologyCitation Excerpt :In this way, even the local toxicity of the metal should be remarkably reduced (Nielsen and Andersen, 1991; Andersen and Molecular, 2002). Importantly, data from animal studies have shown that DMPS does not redistribute the mercury to the brain subsequent to the following exposure to mercury chloride (Planas-Bohne, 1981; Nielsen and Andersen, 1991; Aposhian et al., 1992). Despite the acknowledged mercury-mobilizing proprieties in various human clinical studies, DMPS administrated in mercury poisoned animal model has failed to remove the mercury from tissues (Aposhian et al., 2003).